IntellipharmaCeutics Inc. has announced its annual earnings for the first Quarter of FY-2015.
The results shows the following:
Revenues down 76.6%, Operating Loss down 136% and EPS Downs 144%.
View the full earnings release here.
IntellipharmaCeutics Inc. has announced its annual earnings for the first Quarter of FY-2015.
The results shows the following:
Revenues down 76.6%, Operating Loss down 136% and EPS Downs 144%.
View the full earnings release here.